Form D · Biotechnology
INTENSITY THERAPEUTICS, INC.
Shelton, CT · CIK 0001567264
Offering snapshot reported Dec 5, 2024 · SEC filing
- Reported sold
- $3.65M Offering amount: $3.65M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 21, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 5, 2024 | Initial | $3,649,483 | No comparison | 1 | SEC filing |
| Jun 12, 2015 | Initial | $500,000 | No comparison | 1 | SEC filing |
| Dec 2, 2014 | Amendment | $1,750,000 | $750,000vs Feb 11, 2014 | 20 | SEC filing |
| Feb 11, 2014 | Amendment | $1,000,000 | $825,000vs Jan 18, 2013 | 11 | SEC filing |
| Jan 18, 2013 | Initial | $175,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $120K
- Finders' fees
- $100K
- Form D file number
- 021-531169
Represents the aggregate exercise price of warrants for 1,237,113 shares of common stock issued in connection with a registered direct offering of 1,237,113 shares of common stock
$119,999.96 is for a fee of 4.0% of the gross proceeds of the sale of securities in the registered direct offering and concurrent private placement of warrants, and up to $100,000 is for the reimbursement of expenses incurred by the placement agent.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| A.G.P./Alliance Global Partners | 8361 | |
| Brookline Capital Markets, a division of Arcadia Securities, LLC | 44656 |
Source: Form D, filed Dec 5, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Lewis H. Bender | Director, Executive |
| Robert Cooke | Executive |
| Daniel Donovan | Director |
| Thomas I.H. Dubin | Director |
| Mark A. Goldberg | Director |
| Emer Leahy | Director |
| Joseph Talamo | Executive |
| Ian B. Walters, M.D. | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1 Enterprise Drive, Suite 430
Shelton, CT, 06484
Shelton, CT, 06484